Pacific Biosciences of California (PACB) PT Raised to $1.70 at Bernstein SocGen Group
Tweet Send to a Friend
Bernstein SocGen Group analyst Eve Burstein raised the price target on Pacific Biosciences of California (NASDAQ: PACB) to $1.70 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
